E-LIB Suche - Ergebnisse für: GOEMANS, N

1

Selective pressures of platinum compounds shape the evoluti..:

Bertrums, Eline J. M. ; de Kanter, Jurrian K. ; Derks, Lucca L. M....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Optimized cytogenetic risk-group stratification of KMT2A-re..:

van Weelderen, Romy E. ; Harrison, Christine J. ; Klein, Kim...
Blood Advances. 8 (2024) 12 - p. 3200-3213 , 2024

Link: https://doi.org/10.1182/..

3

PCR28 Characterization of Patients with Duchenne Muscular D..:

Muntoni, F. ; Goemans, N. ; Posner, N....
Value in Health. 26 (2023) 6 - p. S316-S317 , 2023

Link: https://doi.org/10.1016/..

4

P40 Long-term effects of corticosteroid treatment in DMD: d..:

Ikelaar, N. ; van der Holst, M. ; Meijer - Krom, Y....
Neuromuscular Disorders. 33 (2023) - p. S107 , 2023

Link: https://doi.org/10.1016/..

5

C.2 SUNFISH parts 1 and 2: 4-year efficacy and safety data ..:

Mah, JK ; Oskoui, M ; Day, JW...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50 (2023) s2 - p. S51-S52 , 2023

Link: https://doi.org/10.1017/..

6

Functional and Clinical Outcomes Associated with Steroid Tr..:

McDonald, Craig M. ; Mayer, Oscar H. ; Hor, Kan N....
Journal of Neuromuscular Diseases. 10 (2023) 1 - p. 67-79 , 2023

Link: https://doi.org/10.3233/..

7

P37 Givinostat in DMD: results of the Epidys Study with par..:

Mercuri, E. ; Brogna, C. ; Mah, J....
Neuromuscular Disorders. 33 (2023) - p. S106 , 2023

Link: https://doi.org/10.1016/..

8

P140 Predicting long-term trajectories of the North Star Am..:

Muntoni, F. ; Signorovitch, J. ; Goemans, N....
Neuromuscular Disorders. 33 (2023) - p. S82 , 2023

Link: https://doi.org/10.1016/..

9

P138 Development and evaluation of a composite time-to-prog..:

McDonald, C. ; Muntoni, F. ; Marden, J....
Neuromuscular Disorders. 33 (2023) - p. S82 , 2023

Link: https://doi.org/10.1016/..

10

Measurable residual disease and fusion partner independentl..:

van Weelderen, Romy E ; Klein, Kim ; Harrison, Christine J...
Journal of Clinical Oncology, 0732-183X, 2023, 41:16, s. 2963-2974. , 2023

Link: http://urn.kb.se/resolve..

11

Measurable Residual Disease and Fusion Partner Independentl..:

van Weelderen, Romy E ; Klein, Kim ; Harrison, Christine J...
info:eu-repo/semantics/altIdentifier/pmid/36996387. , 2023

Link: https://hdl.handle.net/1..

12

Comprehensive molecular and clinical characterization of NU..:

Bertrums, Eline J.M ; Smith, Jenny L ; Harmon, Lauren...
https://pure.au.dk/portal/en/publications/4b76655d-811f-41f8-a76f-e49b6f44ba27. , 2023

Link: https://pure.au.dk/porta..

13

Measurable Residual Disease and Fusion Partner Independentl..:

van Weelderen, Romy E ; Klein, Kim ; Harrison, Christine J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414713/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Comprehensive molecular and clinical characterization of NU..:

Bertrums, Eline J. M ; Smith, Jenny L ; Harmon, Lauren...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388277/. , 2023

Link: http://www.ncbi.nlm.nih...

15

P.126 Genotype-unmatched controls are feasible for drug dev..:

Muntoni, F. ; Signorovitch, J. ; Frean, M....
Neuromuscular Disorders. 32 (2022) - p. S100 , 2022

Link: https://doi.org/10.1016/..